• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Study highlights trends and outcomes of bronchodilator use in infants with bronchiolitis

byMolly MunsellandAlex Gipsman, MD
July 21, 2021
in Infectious Disease, Pediatrics, Pulmonology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In a large retrospective study, the rate of bronchodilator use during emergency visits for infants with bronchiolitis decreased from 51.5% to 22.8% between 2010 and 2018.

2. High versus low rates of early bronchodilator use at a hospital level were not associated with a statistically significant difference in rates of hospital admissions, ICU admissions, return ED visits, or ventilatory support.

Evidence Rating Level: 2 (Good)

Study Rundown: Bronchiolitis is a common lower respiratory tract infection and is one of the leading causes of hospitalization in infants. The American Academy of Pediatrics (AAP) recommends against the routine use of bronchodilators in managing bronchiolitis based on extensive literature showing that they are not beneficial. In this study, researchers examined trends in bronchodilator use and outcomes between 2010 and 2018 in a large cohort (>450,000 ED visits) of infants with bronchiolitis. Bronchodilator use decreased by about two thirds, and there was a small but significant decrease in hospital admissions and repeat ED visits within 3 days of initial discharge during the study period. However, there were also increases in intensive care unit (ICU) admissions, noninvasive ventilation, and invasive ventilation. It is possible that decreased bronchodilator use played a role in this increased need for intensive support, though causation could not be determined from the study given its design. In comparing hospitals with the highest versus lowest rates of bronchodilator use, there were no significant differences in outcome measures. The large sample size and multi-center design strengthen the generalizability of this study, although its retrospective database design precludes determination of causality. Overall, it supports previous literature in showing that bronchodilators likely have a limited role in the management of acute bronchiolitis.

Click to read the study in Pediatrics

Relevant Reading: Therapeutic strategies for pediatric bronchiolitis

In-Depth [retrospective cohort]: This was a retrospective study across 49 tertiary pediatric hospitals in the United States. Data were obtained from a centralized administrative database, the Pediatric Health Information System. Infants <12 months old presenting to the ED with bronchiolitis from 2010 to 2018 were included; patients with complex chronic diseases were excluded. The median age was 5 months, and 32% of patients overall received bronchodilators. Bronchodilator use decreased from 51.5% to 22.8% (OR 0.83 for linear trend by year). Hospital admissions increased from 2.4% to 4.3%, ICU admissions increased from 2.4% to 4.3%, and repeat ED visits decreased from 5.9% to 5.2%. Noninvasive ventilation increased from 1% to 2.9% (OR 1.15), while invasive ventilation increased from 0.7% to 1.5% (OR 1.06). All of these changes were statistically significant. 111,310 infants were included in the outcomes analysis, divided into two groups based on treatment at hospitals in the highest and lowest quartiles of bronchodilator use on the day of ED presentation. High-use hospitals also had lower overall admission rates from the ED, higher ED volumes, and higher median bronchiolitis severity (based on APR-DRG scores). Although none of the between-group differences were statistically significant, hospitals with high bronchodilator use had lower hospital admissions (32.0% vs. 33.6%), higher ICU admissions (4.7% vs. 3.2%), higher return ED visits (5.7% vs. 5.0%), higher noninvasive ventilation (2.6% vs. 0.8%), and higher invasive ventilation (1.1% vs. 0.1%).

RELATED REPORTS

Molnupiravir and nirmatrelvir-ritonavir reduce COVID-19 mortality in hospitalized patients

Mycobacterium abscessus infections after cardiac surgery linked to hospital water system

Symptom and viral relapse more common in COVID-19 patients without antiviral treatment

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: bronchiolitisinfectious disease
Previous Post

#VisualAbstract Low-dose rotational skin electron beam therapy objectively improves lesions caused by mycosis fungoides and improves skin-related quality of life

Next Post

Filgotinib effectively induces and maintains clinical remission in patients with ulcerative colitis

RelatedReports

SARS-CoV-2 detected on various surroundings of asymptomatic COVID-19 positive infant
Infectious Disease

Molnupiravir and nirmatrelvir-ritonavir reduce COVID-19 mortality in hospitalized patients

March 29, 2023
Standardized central line care practices reduce bloodstream infections
Infectious Disease

Mycobacterium abscessus infections after cardiac surgery linked to hospital water system

March 23, 2023
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

Symptom and viral relapse more common in COVID-19 patients without antiviral treatment

March 21, 2023
Oral amoxicillin as effective as injectable benzylpenicillin-gentamicin for infants with infection in which referral not possible [AFRINEST Trial]
Infectious Disease

Combination doxycycline and azithromycin therapy effective in treating severe scrub typhus

March 20, 2023
Next Post
Elective colectomy associated with improved survival in ulcerative colitis

Filgotinib effectively induces and maintains clinical remission in patients with ulcerative colitis

#VisualAbstract Head and neck melanomas have high-local recurrence risk features and require more frequent tissue-rearranging reconstruction than basal cell and squamous cell carcinomas

#VisualAbstract Head and neck melanomas have high-local recurrence risk features and require more frequent tissue-rearranging reconstruction than basal cell and squamous cell carcinomas

#VisualAbstract Obesity and body weight was not correlated with survival outcomes in patients with relapsed/refractory large B-cell lymphoma treated with CAR T-Cell therapy

#VisualAbstract Obesity and body weight was not correlated with survival outcomes in patients with relapsed/refractory large B-cell lymphoma treated with CAR T-Cell therapy

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring
  • Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma
  • Lebrikizumab effective in treating moderate-to-severe atopic dermatitis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options